The status and analysis of common mutations found in the SARS-CoV-2 whole genome sequences from Bangladesh.
+ssRNA, positive single-stranded RNA
ACE2, Angiotensin-Converting Enzyme 2
Block mutation
CDK, Cyclin Dependent Kinases
COX2, Cyclooxygenase 2
CTD, C-terminal Domain
CoVs, Coronaviruses
Common mutations
DGHS, General of Health Services
ECM, Extracellular Matrix Protein
ERGIC, ER-Golgi intermediate compartment
GSK3, Glycogen Synthase Kinase 3
IRF3, Interferon Regulatory Factor 3
NFkB, Nuclear Factor kappa B
NSP, Nonstructural Protein
NTD, N-terminal Domain
ORFs, Open Reading Frames
PLP, Papain-like Protease
RBD, Receptor-Binding Domain
RTC, Replication–Transcription Complex
RdRp, RNA-dependent RNA polymerase
SARS-CoV-2
SNP, Single Nucleotide Polymorphism
SR rich motif
TMPRSS2, Transmembrane Protease Serine 2
sgRNAs, Sub-genomic RNAs
Journal
Gene reports
ISSN: 2452-0144
Titre abrégé: Gene Rep
Pays: United States
ID NLM: 101680713
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
21
05
2021
revised:
30
03
2022
accepted:
31
03
2022
entrez:
11
4
2022
pubmed:
12
4
2022
medline:
12
4
2022
Statut:
ppublish
Résumé
Rapid emergence of covid-19 variants by continuous mutation made the world experience continuous waves of infections and as a result, a huge number of death-toll recorded so far. It is, therefore, very important to investigate the diversity and nature of the mutations in the SARS-CoV-2 genomes. In this study, the common mutations occurred in the whole genome sequences of SARS-CoV-2 variants of Bangladesh in a certain timeline were analyzed to better understand its status. Hence, a total of 78 complete genome sequences available in the NCBI database were obtained, aligned and further analyzed. Scattered Single Nucleotide Polymorphisms (SNPs) were identified throughout the genome of variants and common SNPs such as: 241:C>T in the 5'UTR of Open Reading Frame 1A (ORF1A), 3037: C>T in Non-structural Protein 3 (NSP3), 14,408: C>T in ORF6 and 23,402: A>G, 23,403: A>G in Spike Protein (S) were observed, but all of them were synonymous mutations. About 97% of the studied genomes showed a block of tri-nucleotide alteration (GGG>AAC), the most common non-synonymous mutation in the 28,881-28,883 location of the genome. This block results in two amino acid changes (203-204: RG>KR) in the SR rich motif of the nucleocapsid (N) protein of SARS-CoV-2, introducing a lysine in between serine and arginine. The N protein structure of the mutant was predicted through protein modeling. However, no observable difference was found between the mutant and the reference (Wuhan) protein. Further, the protein stability changes upon mutations were analyzed using the I-Mutant2.0 tool. The alteration of the arginine to lysine at the amino acid position 203, showed reduction of entropy, suggesting a possible impact on the overall stability of the N protein. The estimation of the non-synonymous to synonymous substitution ratio (dN/dS) were analyzed for the common mutations and the results showed that the overall mean distance among the N-protein variants were statistically significant, supporting the non-synonymous nature of the mutations. The phylogenetic analysis of the selected 78 genomes, compared with the most common genomic variants of this virus across the globe showed a distinct cluster for the analyzed Bangladeshi sequences. Further studies are warranted for conferring any plausible association of these mutations with the clinical manifestation.
Identifiants
pubmed: 35399222
doi: 10.1016/j.genrep.2022.101608
pii: S2452-0144(22)00116-9
pmc: PMC8977224
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101608Informations de copyright
© 2022 Published by Elsevier Inc.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Can J Microbiol. 2009 Mar;55(3):254-60
pubmed: 19370068
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Curr Opin Immunol. 2020 Feb;62:79-90
pubmed: 31935567
Acta Pharm Sin B. 2020 Jul;10(7):1228-1238
pubmed: 32363136
New Microbes New Infect. 2021 Mar;40:100838
pubmed: 33520252
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165878
pubmed: 32544429
Lancet. 2021 Feb 6;397(10273):452-455
pubmed: 33515491
Genome Biol. 2020 Dec 23;21(1):304
pubmed: 33357233
Cell. 2021 Apr 29;184(9):2348-2361.e6
pubmed: 33730597
Nature. 2021 Jun;594(7861):19-20
pubmed: 34031583
Evolution. 1985 Jul;39(4):783-791
pubmed: 28561359
Int J Biochem Cell Biol. 2006;38(8):1417-28
pubmed: 16546436
Respir Res. 2020 Dec 1;21(1):318
pubmed: 33261606
Virus Res. 2021 May;297:198390
pubmed: 33737154
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11030-5
pubmed: 15258291
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Pathogens. 2020 Apr 29;9(5):
pubmed: 32365466
Science. 2021 Aug 6;373(6555):648-654
pubmed: 34210893
Microb Pathog. 2021 May;154:104831
pubmed: 33727169
Biochem Biophys Res Commun. 2008 May 2;369(2):287-91
pubmed: 18243139
Gene Rep. 2020 Jun;19:100682
pubmed: 32300673
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Front Public Health. 2020 Apr 30;8:154
pubmed: 32426318
Chembiochem. 2020 Mar 2;21(5):730-738
pubmed: 32022370
PLoS One. 2021 Jul 27;16(7):e0255379
pubmed: 34314447
J Biosci. 2020;45:
pubmed: 32515358
Biophys Chem. 2004 Dec 1;112(1):15-25
pubmed: 15501572
PLoS One. 2012;7(7):e40410
pubmed: 22792305
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W306-10
pubmed: 15980478
Front Microbiol. 2014 Jun 17;5:296
pubmed: 24987391
Comput Biol Med. 2021 Feb;129:104166
pubmed: 33383528